Cilomilast

Palladium-catalyzed dehydrogenation of α-cyclohexene-substituted nitriles to α-aryl nitriles

The development of a practical, inexpensive, and cyanide-free method for synthesizing α-aryl nitriles remains a challenging goal in synthetic chemistry. Here, we report an approach for synthesizing α-aryl nitriles toward achieving this goal, by which α-cyclohexenyl acetonitriles and α-cyclohexenyl alkenyl nitriles are dehydrogenated to α-aryl nitriles.

Treating patients with respiratory disease who smoke

The high prevalence of cigarette smoking in patients with respiratory disease puts them at risk of developing clinically important drug interactions. Cigarette smoking reduces the therapeutic response to certain drugs such as theophyllines through the induction of hepatic cytochrome P450 isoenzymes. Smokers with asthma and patients with COPD have reduced sensitivity to corticosteroids, possibly due to non-eosinophilic airway inflammation, altered glucocorticoid receptor activity or reduced histone deacetylase activity. Although all smokers should be encouraged to stop smoking, there is limited information on the influence of smoking cessation on the therapeutic and anti-inflammatory effects of a number of the drugs used in the treatment of respiratory disease.

Biochemical aspects of inflammation

This review considers biochemical aspects of inflammation. The international literature until December 2006 has been analyzed, with the principal attention paid to the most dynamic problems: enzymology of inflammation, its regulation by hormones and signal transducers, and negative feedbacks, which underlie intensive current studies on pathogenesis, diagnostics, and therapy of inflammation. Such achievements as discoveries of defensins, toll-like receptors, interconnections of inflammation and iron metabolism, the roles of oxidative stress and antioxidant defense, lipoxins, inflammatory components of "non-inflammatory" diseases, and action mechanisms of effective drugs are discussed.